These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 29367096

  • 21. PDGFRα Regulates Follicular Cell Differentiation Driving Treatment Resistance and Disease Recurrence in Papillary Thyroid Cancer.
    Lopez-Campistrous A, Adewuyi EE, Benesch MGK, Ko YM, Lai R, Thiesen A, Dewald J, Wang P, Chu K, Ghosh S, Williams DC, Vos LJ, Brindley DN, McMullen TPW.
    EBioMedicine; 2016 Oct; 12():86-97. PubMed ID: 27682510
    [Abstract] [Full Text] [Related]

  • 22. Monitoring CD8a+ T Cell Responses to Radiotherapy and CTLA-4 Blockade Using [64Cu]NOTA-CD8a PET Imaging.
    Kristensen LK, Christensen C, Alfsen MZ, Cold S, Nielsen CH, Kjaer A.
    Mol Imaging Biol; 2020 Aug; 22(4):1021-1030. PubMed ID: 32086762
    [Abstract] [Full Text] [Related]

  • 23. A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry.
    Zeglis BM, Sevak KK, Reiner T, Mohindra P, Carlin SD, Zanzonico P, Weissleder R, Lewis JS.
    J Nucl Med; 2013 Aug; 54(8):1389-96. PubMed ID: 23708196
    [Abstract] [Full Text] [Related]

  • 24. Synthesis and Evaluation of a Novel 64Cu- and 67Ga-Labeled Neurokinin 1 Receptor Antagonist for in Vivo Targeting of NK1R-Positive Tumor Xenografts.
    Zhang H, Kanduluru AK, Desai P, Ahad A, Carlin S, Tandon N, Weber WA, Low PS.
    Bioconjug Chem; 2018 Apr 18; 29(4):1319-1326. PubMed ID: 29466853
    [Abstract] [Full Text] [Related]

  • 25. Immuno-PET of tissue factor in pancreatic cancer.
    Hong H, Zhang Y, Nayak TR, Engle JW, Wong HC, Liu B, Barnhart TE, Cai W.
    J Nucl Med; 2012 Nov 18; 53(11):1748-54. PubMed ID: 22988057
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of 64Cu radiolabeled anti-hPD-L1 Nb6 for positron emission tomography imaging in lung cancer tumor mice model.
    Jiang J, Zhang M, Li G, Liu T, Wan Y, Liu Z, Zhu H, Yang Z.
    Bioorg Med Chem Lett; 2020 Feb 15; 30(4):126915. PubMed ID: 31926788
    [Abstract] [Full Text] [Related]

  • 27. 64Cu production via the 68Zn(p,nα)64Cu nuclear reaction: An untapped, cost-effective and high energy production route.
    Nelson BJB, Leier S, Wilson J, Wuest M, Doupe J, Andersson JD, Wuest F.
    Nucl Med Biol; 2024 Feb 15; 128-129():108875. PubMed ID: 38199184
    [Abstract] [Full Text] [Related]

  • 28. PET imaging of insulin-like growth factor type 1 receptor expression with a 64Cu-labeled Affibody molecule.
    Su X, Cheng K, Liu Y, Hu X, Meng S, Cheng Z.
    Amino Acids; 2015 Jul 15; 47(7):1409-19. PubMed ID: 25854877
    [Abstract] [Full Text] [Related]

  • 29. Development of [⁶⁴Cu]-DOTA-PR81 radioimmunoconjugate for MUC-1 positive PET imaging.
    Alirezapour B, Rasaee MJ, Jalilian AR, Rajabifar S, Mohammadnejad J, Paknejad M, Maadi E, Moradkhani S.
    Nucl Med Biol; 2016 Jan 15; 43(1):73-80. PubMed ID: 26453525
    [Abstract] [Full Text] [Related]

  • 30. ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer.
    Sun H, England CG, Hernandez R, Graves SA, Majewski RL, Kamkaew A, Jiang D, Barnhart TE, Yang Y, Cai W.
    Eur J Nucl Med Mol Imaging; 2016 Nov 15; 43(12):2169-2179. PubMed ID: 27342417
    [Abstract] [Full Text] [Related]

  • 31. Synthesis and evaluation of 64Cu-radiolabeled NOTA-cetuximab (64Cu-NOTA-C225) for immuno-PET imaging of EGFR expression.
    Xu X, Liu T, Liu F, Guo X, Xia L, Xie Q, Li N, Huang H, Yang X, Xin Y, Zhu H, Yang Z.
    Chin J Cancer Res; 2019 Apr 15; 31(2):400-409. PubMed ID: 31156310
    [Abstract] [Full Text] [Related]

  • 32. Novel Radiotracer for ImmunoPET Imaging of PD-1 Checkpoint Expression on Tumor Infiltrating Lymphocytes.
    Natarajan A, Mayer AT, Xu L, Reeves RE, Gano J, Gambhir SS.
    Bioconjug Chem; 2015 Oct 21; 26(10):2062-9. PubMed ID: 26307602
    [Abstract] [Full Text] [Related]

  • 33. PET Imaging of Abdominal Aortic Aneurysm with 64Cu-Labeled Anti-CD105 Antibody Fab Fragment.
    Shi S, Orbay H, Yang Y, Graves SA, Nayak TR, Hong H, Hernandez R, Luo H, Goel S, Theuer CP, Nickles RJ, Cai W.
    J Nucl Med; 2015 Jun 21; 56(6):927-32. PubMed ID: 25883125
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.
    Chen Q, Meng X, McQuade P, Rubins D, Lin SA, Zeng Z, Haley H, Miller P, González Trotter D, Low PS.
    Mol Pharm; 2016 May 02; 13(5):1520-7. PubMed ID: 27054811
    [Abstract] [Full Text] [Related]

  • 36. Positron emission tomography imaging of CD105 expression with a 64Cu-labeled monoclonal antibody: NOTA is superior to DOTA.
    Zhang Y, Hong H, Engle JW, Bean J, Yang Y, Leigh BR, Barnhart TE, Cai W.
    PLoS One; 2011 May 02; 6(12):e28005. PubMed ID: 22174762
    [Abstract] [Full Text] [Related]

  • 37. Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.
    Zeglis BM, Brand C, Abdel-Atti D, Carnazza KE, Cook BE, Carlin S, Reiner T, Lewis JS.
    Mol Pharm; 2015 Oct 05; 12(10):3575-87. PubMed ID: 26287993
    [Abstract] [Full Text] [Related]

  • 38. Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses.
    Houghton JL, Zeglis BM, Abdel-Atti D, Sawada R, Scholz WW, Lewis JS.
    J Nucl Med; 2016 Mar 05; 57(3):453-9. PubMed ID: 26471693
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.